• Document download center

    Here you will find all the product information, technical and support documents relating to our protein biomarker panels. Most of these documents apply to our current product portfolio only, but the Data Validation documents for our discontinued panels are also available below.

  • Validation Data documents

    Here you can access full validation data information for both current and discontinued Olink panels.

    • CARDIOMETABOLIC

      panel uses a 1:2025 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 2025 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data.

    • CELL REGULATION
    • CARDIOVASCULAR II
    • CARDIOVASCULAR III

      Note: the CVD III panel uses a 1:100 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 100 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data.

    • DEVELOPMENT

      panel uses a 1:100 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 100 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data.

    • IMMUNE RESPONSE
    • IMMUNO-ONCOLOGY
    • INFLAMMATION
    • METABOLISM

      Note: the Metabolism panel uses a 1:10 dilution of sample. The measuring ranges shown in Figure 3 correspond to the concentrations in the original biological sample, whereas the figures quoted in Table 1 represent the actual concentration of recombinant analyte measurable in the validation assay. A multiplication factor of 10 should therefore be taken into consideration when comparing the addressable biological concentration to the in vitro validation data.

    • NEUROLOGY
    • ONCOLOGY II
    • ORGAN DAMAGE
    • CVD I (discontinued)
    • Oncology I, v2 (discontInued)
  • Biomarker lists

    Here you can access the complete biomarker assay list for each panel, listing the long name, short name and UniProt number for each protein. Since an individual protein may have a number of commonly used names or abbreviations, we recommend using the UniProt ID provided to search the UniProt website if there is any uncertainty.

    To view all of the biomarker assays available in our current portfolio, please go to our Complete Biomarker List page, where you can also link directly to the individual biomarker pages that display the relevant validation data.

    • CARDIOMETABOLIC
    • CELL REGULATION
    • CARDIOVASCULAR II
    • CARDIOVASCULAR III
    • DEVELOPMENT
    • IMMUNE RESPONSE
    • IMMUNO-ONCOLOGY
    • INFLAMMATION
    • METABOLISM
    • NEUROLOGY
    • ONCOLOGY II
    • ORGAN DAMAGE
    • CVD I (discontinued)

      Reference list for customers who have previously used this discontinued panel

    • Oncology I v2 (discontinued)

      Reference list for customers who have previously used this discontinued panel

  • Flyers

    Here you can download flyers that overview our product offering.

    • Olink product offering
  • Manuals & instructions

    Below you will find all our technical user documentation, including manuals, short instructions and guidelines.

    • User Manual
    • Short Instructions
    • Sample Dilution Guideline 1:10
    • Sample Dilution Guidelines 1:100
    • Sample Dilution Guideline 1:2025
  • Material Safety Data Sheets (MSDS)

    Please view our safety information documents relating to the different components of the panel kits.

  • Data analysis files

    For data analysis (.plt ) files please go to the Data analysis page.